|
|
 |
|
Viewing report
|
|
|
|
Competitor Analysis: Anti-Infective Peptides
La Merie, Jan 2009, Pages: 41
The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective peptides as of January 2009. Stages of the anti-infective peptide R&D projects range from early research to market.
Anti-Viral Peptides:
Anti-viral peptides are used to treat infections such as HIV and AIDS, influenza incl. H5N1 strains, hepatitis C virus infections (HCV).
Anti-Bacterial Peptides:
Anti-bacterial peptides are used to treat infectious diseases such as complicated skin and skin structure infections (cSSSI), gram+ and gram- infections, prevention of catheter-related infections, otitis media, gingivitis and many more.
Anti-Fungal Peptides:
Anti-fungal peptides are used to treat infections such as oesophageal candidiasis, aspergillosis, oral candida infections, vaginal yeast infections and many more
Customers who bought this item also bought
Infections Fungal Infections or Candidiasis
Competitor Analysis: PTH Receptor Agonists
Infections - Fungal Infections or Candidiasis Drug Pipeline Report
Infections Bacterial Infections
Bacterial Infections: An Epidemiological Overview
Bacterial Infections: An Epidemiological Overview
The Anti-Infectives Market Outlook to 2013: Competitive Landscape, Pipeline Analysis and Growth Opportunities
Stakeholder Opinions: Nosocomial Infections - The Need for New Gram-negative Drugs
The Global Anti-Infectives Market Outlook to 2011
The 2009-2014 World Outlook for Anti-Infective Pharmaceutical Preparations Affecting Anthelminics
The 2009-2014 Outlook for Anti-Infective Pharmaceutical Preparations Affecting Anthelminics in Japan
The 2009 Report on Anti-Infective Pharmaceutical Preparations Affecting Amebacides and Trichomonicides: World Market Segmentation by City
|
|
|
|
